Skip to content

Effects of Adding Chickpeas to the American Diet (Long Term Study)

Effects of Adding Chickpeas to the American Diet on Fecal Microbiota Composition and Markers of Inflammation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02375373
Enrollment
12
Registered
2015-03-02
Start date
2015-04-30
Completion date
2015-12-31
Last updated
2016-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation

Keywords

Gut Microbiota

Brief summary

This prospective study will assess the effects of adding legumes, especially chick peas, to the diet of healthy adults on the commensal bacteria from feces of human subjects and resulting self-reported GI symptoms as well as markers of immune function.

Detailed description

Long-term observational study: Subjects enrolled will participate in an observational setting for three months. During this time period, individuals will be encouraged, to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods. Fecal samples for microbiota analysis will be collected every month. Participants will record a weekly online questionnaire about legume intake and GI health as well as other health status updates. While participants will be encouraged to maintain regular intake of chickpeas throughout the long-term study, consumption of other legumes will be encouraged.

Interventions

OTHERObservational Chickpea Diet

Individuals encouraged to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods. Fecal samples collected monthly.

Sponsors

American Pulse Association
CollaboratorOTHER
University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Good Health * No systemic antibiotics during the preceding two months * No medication suppressing immune function * Willingness to provide basic demographic as well as medical history data

Exclusion criteria

* Gastric Ulcers * Inflammatory Bowel Disease (IBD) or Irritable Bowel Syndrome (IBS) * Chronic constipation/diarrhea * Body Mass Index (BMI) \> 30 * Dietary restrictions that prevent legume intake * Currently on any medication that can affect GI transit time * Consumption of \>3 servings/week of chickpeas or \>6 servings/week of legumes BEFORE study begins

Design outcomes

Primary

MeasureTime frameDescription
Changes in Number of 16S RNA Sequences on Days 31, Day 62, and Day 93.Change from Day 31, Day 62, and Day 93Compare the gut microbiota composition of individual subjects before and after the implementation of a controlled and observed diet of chickpeas and legume products.

Countries

United States

Participant flow

Participants by arm

ArmCount
Obersvational Chickpea Diet
Observed long-term to study legume intake and GI health (Observational Chickpea Diet) Observational Chickpea Diet: Individuals encouraged to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods. Fecal samples collected monthly.
12
Total12

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject11

Baseline characteristics

CharacteristicObersvational Chickpea Diet
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
Region of Enrollment
United States
12 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Changes in Number of 16S RNA Sequences on Days 31, Day 62, and Day 93.

Compare the gut microbiota composition of individual subjects before and after the implementation of a controlled and observed diet of chickpeas and legume products.

Time frame: Change from Day 31, Day 62, and Day 93

Population: Due to the rate of withdrawal from this study only one participant completed and this data was used for the outcome measures.

ArmMeasureGroupValue (MEAN)
Obersvational Chickpea DietChanges in Number of 16S RNA Sequences on Days 31, Day 62, and Day 93.Day 3149171 sequences
Obersvational Chickpea DietChanges in Number of 16S RNA Sequences on Days 31, Day 62, and Day 93.Day 6248925 sequences
Obersvational Chickpea DietChanges in Number of 16S RNA Sequences on Days 31, Day 62, and Day 93.Day 9349053 sequences

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026